Abbott (ABT) Q4 Earnings Match Estimates
Abbott (ABT) came out with quarterly earnings of $1.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.03 per share a year ago. These figures are adjusted for non...
- Supported exchanges /
- F /
- EP3.F
OraSure Technologies Inc (EP3 F) stock market data APIs
€3.8
0(0%)
as of November 4, 2024
Price chart is built with Anychart
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
OraSure Technologies Inc Financial Data Overview
| 3.8 | |
| 3.8 | |
| - | |
| 3.8 | |
| 3.8 | |
| 3.6-7.5 | |
| 293 M | |
| 11.5152 | |
| 74 568 K | |
| 274 M | |
| 0.045 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'EP3',
Type:
'Common Stock',
Name:
'OraSure Technologies Inc',
Exchange:
'F',
CurrencyCode:
'EUR',
CurrencyName:
'Euro',
CurrencySymbol:
'€',
CountryName:
'Germany',
CountryISO:
'DE',
OpenFigi:
NULL,
ISIN:
NULL,
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Medical Instruments & Supplies',
CUSIP:
NULL,
}
OraSure Technologies Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 274 M
- EBITDA 31 481 K
- Earnings Per Share 0.33
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get OraSure Technologies Inc Earnings via APIs
- Latest Release 2024-11-06
- EPS/Forecast NaN
Get OraSure Technologies Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get OraSure Technologies Inc latest news via APIs
Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron
For Immediate Release Chicago, IL – January 19, 2024 – Stocks in this week’s article are Otter Tail Corp. OTTR, OraSure Technologies Inc. OSUR, BioMarin Pharmaceutical Inc. BMRN and Regeneron P...
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
